Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Tomohiro Eguchi"'
Autor:
Satoshi Hara, Tama Sanatani, Natsuo Tachikawa, Yukihiro Yoshimura, Nobuyuki Miyata, Hiroaki Sasaki, Risa Kuroda, Chinatsu Kamikokuryo, Tomohiro Eguchi, Shuhei Niiyama, Yasuyuki Kakihana, Hiroshi Ichinose
Publikováno v:
Heliyon, Vol 8, Iss 5, Pp e09371- (2022)
Background: Neopterin (NP) is a biomarker for activated cellular immunity and is elevated in diseases including viral and bacterial infections, autoimmune diseases, and cancer. However, the clinical assessment of neopterin has not been used for these
Externí odkaz:
https://doaj.org/article/08bdf100546844748a192ce65ec1558a
Autor:
Shotaro Miyamoto, Takashi Ito, Shinsaku Terada, Tomohiro Eguchi, Hiroaki Furubeppu, Hideki Kawamura, Tomotsugu Yasuda, Yasuyuki Kakihana
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-6 (2019)
Abstract Background Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral infectious disease with high mortality. It causes multiple organ dysfunction; however, myocarditis has never been reported as a complication with SFTS. Case p
Externí odkaz:
https://doaj.org/article/d32176659b354c41ba633c1a80b68d50
Autor:
Takuro Arishima, Takashi Ito, Tomotsugu Yasuda, Nozomi Yashima, Hiroaki Furubeppu, Chinatsu Kamikokuryo, Takahiro Futatsuki, Yutaro Madokoro, Shotaro Miyamoto, Tomohiro Eguchi, Hiroyuki Haraura, Ikuro Maruyama, Yasuyuki Kakihana
Publikováno v:
Thrombosis Journal, Vol 16, Iss 1, Pp 1-7 (2018)
Abstract Background Recombinant human soluble thrombomodulin (rTM) has been used for the treatment of disseminated intravascular coagulation in Japan, and an international phase III clinical trial for rTM is currently in progress. rTM mainly exerts i
Externí odkaz:
https://doaj.org/article/da843b2c0fd24c6f91b2e21f13318f91
Autor:
Taro, Horino, Tomohiro, Eguchi, Satoshi, Inotani, Akira, Hirose, Masayuki, Ishihara, Kenichi, Yagyu, Kazushige, Uchida, Mikiya, Fujieda, Yoshio, Terada
Publikováno v:
Internal Medicine. 62:91-94
Vascular endothelial growth factor inhibitors and checkpoint inhibitors are effective treatments for solid tumors. These new classes of anti-cancer agents frequently cause kidney-related side effects. Although their anti-cancer effects may be enhance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d10364ef6d46e506f99c8bf71088cd8
https://doi.org/10.2169/internalmedicine.9425-22
https://doi.org/10.2169/internalmedicine.9425-22
Autor:
Hidehito Kotani, Hiroshi Hirai, Nobuhiko Kawanishi, Toshiyasu Shimomura, Hiraku Itadani, Tomohiro Eguchi
Supplementary Fig. S4 from Expression levels of p18INK4C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::046ac19d94bb20c05a3d1be1559d0bfd
https://doi.org/10.1158/1535-7163.22485974.v1
https://doi.org/10.1158/1535-7163.22485974.v1
Autor:
Hidehito Kotani, Hiroshi Hirai, Nobuhiko Kawanishi, Toshiyasu Shimomura, Hiraku Itadani, Tomohiro Eguchi
Supplementary Table S1 from Expression levels of p18INK4C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::397537b0fb9063c4d6fd2aa21acdf1a4
https://doi.org/10.1158/1535-7163.22485971.v1
https://doi.org/10.1158/1535-7163.22485971.v1
Publikováno v:
Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 27(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05726b95b24f5cac1bcc2280b1afa46f
https://pubmed.ncbi.nlm.nih.gov/33755033
https://pubmed.ncbi.nlm.nih.gov/33755033
Autor:
Junichiro Taniguchi, Shinsaku Terada, Yasuyuki Kakihana, Takahiro Futatsuki, Yutaro Madokoro, Tomotsugu Yasuda, Shotaro Miyamoto, Tomohiro Eguchi
Publikováno v:
Journal of the Japanese Society of Intensive Care Medicine. 25:383-388
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::653f0dba4d7d7d9e7a6bf3ce1fe7e7d4
https://doi.org/10.3918/jsicm.25_383
https://doi.org/10.3918/jsicm.25_383
Autor:
Tomotsugu Yasuda, Ikuro Maruyama, Tomohiro Eguchi, Yutaro Madokoro, Yasuyuki Kakihana, Takahiro Futatsuki, Shotaro Miyamoto, Hiroyuki Haraura, Nozomi Yashima, Hiroaki Furubeppu, Takashi Ito, Chinatsu Kamikokuryo, Takuro Arishima
Publikováno v:
Thrombosis Journal, Vol 16, Iss 1, Pp 1-7 (2018)
Thrombosis Journal
Thrombosis Journal
Background Recombinant human soluble thrombomodulin (rTM) has been used for the treatment of disseminated intravascular coagulation in Japan, and an international phase III clinical trial for rTM is currently in progress. rTM mainly exerts its antico
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe881903b7ac9ffd7fc135bea13624f5
http://link.springer.com/article/10.1186/s12959-018-0178-0
http://link.springer.com/article/10.1186/s12959-018-0178-0
Autor:
Tomotsugu Yasuda, Kazumitsu Shiraishi, Shuhei Niiyama, Shota Yamashita, Tomohiro Eguchi, Shinsaku Terada, Yasuyuki Kakihana, Yutaro Madokoro
Publikováno v:
Journal of the Japanese Society of Intensive Care Medicine. 27:125-126
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77992afc0ad4ecc3531d59ac83e2131a
https://doi.org/10.3918/jsicm.27_125
https://doi.org/10.3918/jsicm.27_125